Dados B3 › ESPA3 × HYPE3
ESPA3 × HYPE3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | ESPA3 | HYPE3 | year |
|---|---|---|---|
| ROE | 1.8% | 9.7% | 2025 |
| ROIC | 6.4%! | 8.8%! | 2025 |
| ROA | 0.6% | 4.8% | 2025 |
| Gross margin | 34.1% | 59.0% | 2025 |
| EBIT margin | 15.7% | 22.9% | 2025 |
| Net margin | 1.2% | 15.5% | 2025 |
| Net debt/EBITDA | 2.30x | 3.68x | 2025 |
| Current ratio | 1.69x | 1.47x | 2025 |
| Revenue growth (1y) | 6.1% | 3.4% | 2025 |
| Revenue growth (5y CAGR) | 15.9% | 13.5% | 2025 |
| Piotroski F-Score | 8/9 | 7/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | ESPA3 | HYPE3 | year |
|---|---|---|---|
| P/E | 27.03x | 11.30x | 2025 |
| P/B | 0.49x | 1.08x | 2025 |
| EV/EBITDA | 3.91x | 10.17x | 2025 |
| FCF yield | 14.8% | 13.1% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:16 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:16 UTC. If this does not match /saude, you are reading a cached copy.